Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
8.69
-0.41 (-4.51%)
Jan 29, 2026, 3:11 PM EST - Market open
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $7.29 million as of January 29, 2026. Its market cap has increased by 43.28% in one year.
Market Cap
7.29M
Enterprise Value
4.70M
1-Year Change
43.28%
Ranking
Category
Stock Price
$8.69
Market Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $7.29M, a decrease of -92.50%. That is a compound annual growth rate of -45.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 7.63M | -36.94% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MetaVia | 8.34M |
| Alzamend Neuro | 8.29M |
| Aptevo Therapeutics | 8.24M |
| GT Biopharma | 7.86M |
| Kiora Pharmaceuticals | 7.67M |
| Addex Therapeutics | 7.58M |
| Creative Medical Technology Holdings | 7.55M |
| Mustang Bio | 7.44M |